Recombinant Human Animal-Free MMP-2 Protein (HEK293)，His

Matrix metalloproteinase-2 (MMP-2) is a key enzyme involved in the remodeling of the extracellular matrix, playing a critical role in various physiological processes, such as tissue repair, angiogenesis, and cell migration, as well as pathological conditions, including cancer metastasis and fibrosis. Traditionally, MMP-2 has been sourced from animal tissues, posing ethical concerns, variability in yield, and risks of contamination with pathogens. The development of animal-free recombinant proteins has emerged as a pioneering approach to overcome these limitations. Through biotechnological advancements, researchers can now utilize expression systems such as yeast, bacteria, or plant cells to produce MMP-2 in a controlled, reproducible manner. This not only ensures higher purity and consistency but also addresses ethical issues associated with animal use. Additionally, animal-free production methods facilitate easier scalability and enable the potential for post-translational modifications that enhance the enzymatic activity and stability of the protein. The growing interest in recombinant MMP-2 is underscored by its therapeutic potential in treating fibrotic diseases, cardiovascular disorders, and cancer, making it a valuable focus of research in biomedicine and biotechnology. The shift towards animal-free methods marks a significant advancement in the production of biopharmaceuticals, aligned with global trends toward sustainability and ethical responsibility in scientific research.